针对骨髓质疏松症候群和急性骨髓性白血病的免疫疗法:我们站在哪里?
David R Spillane1, Sarit Assouline1
1Jewish General Hospital, McGill University, Montreal, Québec, Canada.
Expert review of hematology
|October 11, 2023
概括
免疫疗法在肌肉分裂性综合征 (MDS) 和急性肌肉性白血病 (AML) 中显示出有前途的发展. 虽然早期的试验面临挑战,但新的方法,如双特异性抗体和细胞疗法,为这些预后不佳的髓状细胞癌提供了更好的疗效和耐受性.
科学领域:
- 在瘤学瘤学.
- 免疫学 免疫学 免疫学
背景情况:
- 骨髓质疏松症候群 (MDS) 和急性骨髓性白血病 (AML) 是具有不良预后的侵袭性血液恶性瘤.
- 目前用于MDS和AML的治疗方法的疗效有限,这凸显了对新型治疗策略的需求.
研究的目的:
- 审查目前针对MDS和AML进行研究的免疫疗法的现状.
- 分析临床试验数据,并讨论骨髓瘤癌症免疫治疗的未来方向.
主要方法:
- 对免疫疗法的全面审查,包括免疫检查点抑制剂,双特异抗体和各种细胞疗法.
- 专注于在MDS和AML患者中评估这些药物的临床试验.
主要成果:
- 在MDS/AML的初始免疫检查点抑制剂试验显示高毒性和低疗效,但正在进行的新药研究更有希望.
- 双特异性抗体和细胞疗法,如自然杀手 (NK) 细胞输液,在早期试验中表现出良好的疗效和耐受性.
结论:
- 免疫疗法是MDS和AML的快速发展和有前途的治疗方式.
- 进一步研究和了解瘤免疫微环境将完善免疫疗法在骨髓性恶性瘤中的应用.
相关概念视频
01:22Bone Marrow Sampling and Transplants
342
Bone marrow transplant is a potential cure for several diseases, including cancer and specific genetic disorders. Notably, this procedure is applicable for patients suffering from aplastic anemia, certain types of leukemia, severe combined immunodeficiency disease (SCID), Hodgkin's disease, non-Hodgkin's lymphoma, multiple myeloma, thalassemia, sickle-cell disease, and certain cancers.
The transplant begins with high doses of chemotherapy and radiation treatment, which aim to destroy...
The transplant begins with high doses of chemotherapy and radiation treatment, which aim to destroy...
342
01:27Tumor Immunotherapy
539
Immunotherapy is a treatment that boosts or manipulates the immune system to fight diseases, including cancer. For instance, by stimulating an immune response through vaccinations against viruses that cause cancers, like hepatitis B virus and human papillomavirus, these diseases can be prevented. Nonetheless, some cancer cells can avoid the immune system due to their rapid mutation and division. The immune response to many cancers involves three phases: elimination, equilibrium, and escape.
539